Harnessing the momentum of industry advancement and embracing the journey toward pharmaceutical innovation, the much-anticipated 94th API China was held in Shanghai from May 13 to 15. Jiudian Hongyang Pharmaceutical made a powerful appearance at the event, presenting its core active pharmaceutical ingredients (APIs), high-end pharmaceutical excipients, and one-stop CMO services. With its full-chain service capabilities, the company stood out at this premier industry platform, attracting numerous domestic and international pharmaceutical enterprises for in-depth discussions and collaboration.

A Premier Industry Event with Unprecedented Scale – Three Expos in One

The 94th API China was held jointly with the 92nd National Pharmaceutical Trade Fair and the 2026 China International Health & Nutrition Expo, covering a total exhibition area of 170,000 square meters. The event brought together nearly 4,000 high-quality enterprises from the pharmaceutical, medical, and health nutrition sectors both domestically and internationally, making it the largest and most influential industry exchange platform in China's pharmaceutical field for the first half of 2026. The exhibited product categories spanned over a hundred types and more than 100,000 products, including pharmaceutical preparations, APIs, pharmaceutical excipients, natural products, pharmaceutical packaging, manufacturing equipment, medical consumables, health nutrition products, medical foods, and traditional tonic foods.

Jiudian Hongyang Pharmaceutical placed great importance on this industry event, viewing it as a crucial opportunity to showcase the company's comprehensive strengths, build industry communication bridges, expand its national market presence, and deepen industry cooperation. Mr. Fan, Deputy General Manager of Jiudian Pharmaceutical and General Manager of Jiudian Hongyang, along with Ms. Zhu, Operations Director of Jiudian Pharmaceutical, personally led elite teams from Jiudian Hongyang's API & Excipients Business Unit, Supply Department, and Jiudian Pharmaceutical's Business Cooperation Department to participate in the exhibition, comprehensively presenting the company's upstream and downstream layout in the pharmaceutical industry chain.

Core Products Take Center Stage – Technical Expertise Earns Recognition

At the exhibition, Jiudian Hongyang prominently displayed its core products and technological achievements in the fields of specialty APIs and high-end pharmaceutical excipients. In the excipients sector, the company's exhibited high-end product series – including microcrystalline cellulose, mannitol, glycerol (for injection), lactose, and anhydrous dibasic calcium phosphate – drew significant attention from numerous formulation enterprises due to their stable and reliable quality and superior performance. These products are widely applicable in various dosage forms such as oral preparations and injections, catering to the diverse needs of different customers. In the API sector, Jiudian Hongyang has continuously increased R&D investment, establishing significant large-scale production advantages in specialty varieties such as iron protein succinylate, oseltamivir phosphate, dapagliflozin, and loxoprofen sodium. The company's green synthesis technologies for multiple APIs and pharmaceutical excipients have reached a domestically leading level, fully demonstrating the deep technological accumulation of this R&D-driven enterprise.

Integrated Service Model – Building Core Competitiveness

In addition to high-quality products, the highlight of Jiudian Hongyang's participation this time was its integrated "API + Pharmaceutical Excipient" supply model. This model provides customers with one-stop procurement and total solutions covering both APIs and excipients, effectively reducing procurement costs and supply chain risks while improving production efficiency.

At the same time, Jiudian Pharmaceutical's Business Cooperation Department actively promoted its one-stop CMO services on-site. Leveraging its mature and sound quality system, professional and experienced service teams, and strong resource integration capabilities, the department proactively engaged with both existing and new clients from various regions. Through in-depth exchanges and discussions on CMO cooperation models and industry development prospects, the team precisely matched market cooperation needs on-site, continuously broadened business cooperation channels, and effectively built consensus for collaboration.

During the exhibition, company representatives engaged in deep discussions with numerous domestic top-100 pharmaceutical enterprises and multinational buyers. They exchanged views on key topics including long-term API supply, customized development of high-end excipients, and CMO/CDMO cooperation, reaching multiple important cooperation consensuses. These outcomes laid a solid foundation for the company's future business expansion and further enhanced Jiudian's brand influence in both domestic and international pharmaceutical markets.

This exhibition not only highlighted Jiudian Hongyang's leading advantages in the upstream industrial chain but also comprehensively demonstrated Jiudian Pharmaceutical's full-industry-chain layout and full-service capabilities encompassing "preparations + APIs + pharmaceutical excipients + CMO." It conveyed the company's firm commitment to deeply cultivating the pharmaceutical industry and contributing to the high-quality development of China's pharmaceutical sector. Looking ahead, the company will continue to uphold the philosophy of innovation-driven development, unite the industry's momentum for progress, persist in innovation and collaborative co-creation, deepen domestic and international cooperation, and contribute Jiudian's strength to the high-quality development of the pharmaceutical industry.